Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Citius Pharmaceuticals, Inc. (CTXR)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -55.1% | -58.9% | -107.4% | -93.5% | -78.3% | -60.4% | -104.2% | |
| ROIC (including intangibles) | -48.5% | -32.7% | -66.4% | -62.4% | -71.4% | -52.3% | -43.4% | 252.8% |
| ROE | -32.8% | -17.7% | -52.6% | -57.4% | -49.5% | -45.5% | -44.4% | 235.0% |
| ROA | -29.7% | -16.5% | -40.5% | -42.4% | -44.4% | -40.9% | -33.9% | -435.6% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Days payables outstanding | 4,726.3 | 5,179.3 | 7,528.1 | 11,004.9 | 7,657.4 | 4,397.7 | -7,374.3 | |
| Cash conversion cycle | -4,726.3 | -5,179.3 | -7,528.1 | -11,004.9 | -7,657.4 | -4,397.7 | 7,374.3 | |
|